Guided by an early passion for neuroscience (as a child, I dreamed of being the first neurosurgeon to transplant the human brain!), I began my scientific career leading basic research and drug discovery projects for academic institutions and the pharmaceutical industry in France, Portugal and Belgium. My ambition was to accompany innovative therapies from my laboratory bench to the patient's pharmacy.

I joined the Clinical Research Unit (CRU) of CHU Charleroi-Chimay in 2012 as a Clinical Project Coordinator in order to provide regulatory, administrative and operational supports to the medical departments involved in sponsor-driven clinical research projects (Pharma, university, etc.). Today, as Director of Clinical Research, I am developing and diversifying CRU services towards CRO*-like services and opening them up to external suppliers of AI/robotics-based healthcare solutions. I am currently involved in the establishment of the European certification process (CE marking) for these medical devices as part of the European consortium TEF-Health Testing and Experimentation Facility for Health AI and Robotics, and in the assessment of the value of these solutions in medical deserts (EURAIMA project: European Artificial Intelligence in Medicine Alliance).

Valerie Vandeweerd is a physician-turned-cofounder of Monsana, a healthtech company optimising clinical trial recruitment with AI-driven patient-trial matching. Inspired by personal experience, she combines her medical background and industry expertise to ease the burden on healthcare professionals in accessing innovative treatments.

Jerome de Barros is a policymaker at the European Commission (DG SANTE) with 10+ years of experience in Digital Health programmes and policies. He is developing the European Health Data Space (EHDS) legislation and IT infrastructures with a focus on data quality aspects, and secondary uses of data, including research and innovation.

Prior to joining the Commission, he was the Data Driven Innovation Lead for Health & Care at the University of Edinburgh working, among other projects, on the set up of the DataLoch, a health data infrastructure bringing together and leveraging health and social care data for the South-East Scotland region. 

Since 20107, Alfred Attipoe is founder and CEO of COMUNICARE SOLUTIONS (www.comunicare.be), a spin-off of the university of Liege, that specializes in e-health. The company develops ComuniCare, a software platform that enables better communication between patients and care givers by enforcing patient education, therapeutic compliance and outcome measurement.

Alfred started his career in 1994 as research assistant in the aerospace industry at the European Institute of Cognitive Science (EURISCO) then at Aerospatiale Protection Systèmes (APSYS), both subsidiaries of the Airbus group. Working with multidisciplinary teams in cognitive sciences and ergonomics, his R&D activities involved the traceability of aircraft design information. He specifically worked on the A3XX program.

From 1997 to 2001, as senior consultant at ACSE (SGML Technologie Group) then Software AG after acquisition, he was involved in R&D and pre-sales activities, helping customers in many sectors to transform their business processes with SGML and XML technologies. 

From 2001 to 2008, as IT manager (head of business solutions and member of the group IT committee) at Petercam Group, he oversaw the overall renewal of the IT architecture, handling all aspects of IT alignment to business strategy, IT strategy definition, enterprise application architecture, project management, change management and technology operation. 

In 2009, he founded XELINK, a company that provided solutions for automated trading in the financial markets, especially at KBC securities. 

From 2011, Alfred has held different consulting positions in the healthcare sector (CHU Saint-Pierre Bruxelles, CHIREC Bruxelles, CHR Citadelle Liège), helping these organizations in IT strategy, IT governance and/or project management.  

From 2023, Alfred is associate investor in Beyond Blood Diagnotics, a London based start-up that is currently undertaking to develop an at-home blood count monitoring device to allow for rapid and cost-effective isolation of blood cells with unparalleled accuracy.

Alfred has also been teaching assistant at University of Toulouse between 1994 and 1997, and lecturer of in the executive master program ITMED of the EM2C institute between 2015 and 2019. 

Galaad Altares is a PhD physicist and AI expert with a strong background in computational modeling and data-driven solutions. He has experience in consultancy and has worked extensively in AI, particularly in computer vision in medical applications. Now at the research center Multitel, he focuses on trustworthy AI, ensuring the development of robust, and transparent artificial intelligence systems. His work contributes to AI certification and alignment with the AI Act, ensuring performance, transparency, and reliability.

Emilie is a Junior Associate in the IP/IT & Data Protection team in Belgium, where she assists clients on intellectual property and information technology law matters.

Emilie obtained her law degree from the University of Antwerp in 2021 and holds an LL.M. in intellectual property & ICT law from the Catholic University of Leuven delivered in 2022. She joined Osborne Clarke in 2023.

Jaakko is Data Analyst at AI team at HUS Helsinki University Hospital. He is currently working on building a virtual testing service for Artificial Intelligence in Medical Devices as a part of the Finnish node of the TEF-Health consortium. 

Jaakko holds a MSc in Life Science Technologies from Aalto University. His expertise includes neuroscience, medical imaging techniques and AI.

Martina is Chief Data Officer at Sciensano, the Belgian public health institute. She is currently working on improving the data maturity across the organisation and making its data more findable, interoperable and reusable – namely to gear up for the European Health Data Space (EHDS).

Previously, she worked as a data analyst and data scientist at the Transformation Directorate of NHS England.

Martina holds an MSc in Biomedical Engineering from Imperial College London and a PhD in Medical Physics from University College London.

Marie Bastin is a biomedical engineer holding a degree from the École Polytechnique de Louvain (EPL) at the Université Catholique de Louvain (UCL) with years of experience in data sciences specifically applied to the Healthcare industry. Currently, she is the Data Sciences Services Manager at DNAlytics, where she leads efforts to create healthcare value through digital innovation.

• Product and technology leader with a decade of expertise in healthcare and digital health. Trained as a physician and start-up founder, he specialises in applying AI, machine learning, and smartphone technologies to enhance healthcare delivery. Proven track record in developing solutions for symptom checking, vital parameter measurement, and diagnosing dermatological and respiratory conditions.

Päivi Östling (Associate Professor) has more than ten years of research experience in the field of precision cancer medicine (PCM). She has been responsible for establishing a functional precision medicin (fPM) platform at the Olli Kallioniemi research group at SciLifeLab, Karolinska Institutet (KI). The group generates individualized drug profiles including multi-omics in solid and hematological cancers. Currently, Päivi has an assignment as a Scientific Lead of Precision Medicine at SciLifeLab, with the aim to enable infrastructure for next generation precision medicine. She is part of the Swedish node for the European DIGITAL-project “Testing and Experimentation Facility for Health AI and Robotics” (TEF-Health) providing technical and scientific support for Health AI providers and notified bodies. She also holds key positions of trust within the Swedish Life Science including SWELife, Cancer Research KI, Karolinska Comprehensive Cancer Center Board of Directors, Genomic Medicine Sweden, PREDICT biobank and co-leads the PCM program at KI. Through her research focus, her experience on research infrastructure for precision medicine and her commissions of trust she is well placed to provide valuable insights into the complex landscape of precision medicine, health data and AI.

Johanna Furuhjelm is a accomplished professional with extensive experience in project coordination, innovation, and market intelligence. She currently serves as the Director for Karolinska Institutet Centre for AI Innovation and the deputy node leader and node coordinator for TEF-Health in Sweden.

Previously, Johanna was the Administrative Director for Cancer Research KI, overseeing strategic and operational development of the stratetgic research area at Karolinska Institutet. Her career includes significant roles in market intelligence and business development, within the biotechnology and healthcare sectors. Supporting innovations from academia, start-ups and industry towards the market. She has a strong background in EU project proposal writing and has managed several high-profile research funding programs.

Johanna holds a PhD and MSc in Biosciences from the University of Helsinki. Her expertise spans project management, strategic planning, and the commercialization of research innovations.

Vladimir Murovec boasts a decade of experience as an EU regulatory and compliance lawyer specialising in the Life Sciences and Healthcare sectors. His expertise spans a wide array of areas including medical devices, in vitro diagnostics, (bio)pharmaceuticals, healthcare AI systems and other digital health technologies. 

Clients rely on Vladimir for advice on various regulatory matters, from research and development activities to marketing authorisations, CE-marking procedures, manufacture of products, cross-border distribution, advertising, and product liability risks. Combining extensive in-house secondment experience and a strong academic background, he is recognised as a compliance expert, guiding companies on ethical engagements with healthcare professionals, organisations, and patients' groups. Notably, Vladimir represents both EU and non-EU businesses in dealings with European regulators, national authorities, and industry associations.

With a keen focus on quality management systems (QMS) and good practices (GxP), Vladimir assists in global supply chain decision-making and the implementation of internal procedures.

Vladimir is a sought-after speaker at international industry events, on regulatory and compliance topics in the Life Sciences space. He has taught EU life sciences regulations in business schools and serves as an associate editor of the European Health and Pharmaceutical Law Review (EHPL). He is a member of the international regulatory affairs professional society (RAPS).

Vladimir is recognised by Who's Who Legal (Life Sciences) for his expertise in Regulatory matters. He has been listed as a ‘Rising Star’ and a 'Leading Associate' in The Legal 500 rankings. His work in Healthcare and Life Sciences, as well as in EU Regulatory: Pharma, Medical Device and Biotech, has been acknowledged since 2020.

I am a research engineer at PREDIMED, the Grenoble Alpes University Hospital's clinical data warehouse, in charge of developing the service offering for start-ups and SMEs as part of the TEF-Health project. I'm also deepening my knowledge of medical informatics and data science by preparing a thesis on the use of graphical data models for the analysis of real data from clinical data warehouses.

As technical physician with expertise in artificial intelligence and medical imaging, dr. Kevin Groot Lipman combines technical knowledge with medical insight to advance healthcare technology. Graduating from the University of Twente with a specialization in Technical Medicine—Medical Imaging & Intervention—he laid a strong foundation for his research and clinical implementation work.
Early in his career, he gained hands-on experience at prestigious institutions like the Netherlands Cancer Institute and Massachusetts General Hospital. It allowed him to apply deep learning models to complex medical imaging challenges.
Kevin conducted his PhD research at the Netherlands Cancer Institute, focusing on developing AI algorithms to streamline the evaluation of respiratory diseases. One of his AI models is already implemented at the institute, which demonstrates the practical impact of his research. His expertise also led to a visiting researcher position at the University Hospital of Zurich.
He is Co-PI of two Public-Private-Partnership grants (€1.5M and €1M) aimed at developing foundational models for medical imaging plus ctDNA and AI applications in breast imaging. Moreover, he got a personal grant of €70,000 by the Dutch Pulmonologists Society to further his studies in respiratory disease evaluation. During his Masters, he got second place in the University of Twente's Best Master Thesis competition for Technical Medicine. In the clinics, he integrated his own developed AI models into clinical workflows, improving patient follow-up through the ARTIMES project.
Kevin recently initiated a research direction exploring visual foundational models for radiology. By creating robust embeddings of radiological images, his research can potentially lead to transforming diagnostic practices and automate radiology reporting. He serves as the chairman of the young club of the European Society of Medical Imaging Informatics (EuSoMII), where he aims to strengthen collaboration among early-career clinical and technical professionals in the medical imaging field.

Hans Constandt is a driven social entrepreneur with a rich background in biotechnology, medicine, computer science and postgraduate degrees in Innovation and Entrepreneurship. With a deep belief in that data can save lives, he has dedicated his career to making health information more accessible and efficient.

As a visionary leader, Hans combines strategic insight with a pragmatic approach to support patients and healthcare professionals with smart, data-driven solutions. He advises patient organisations, startups, scale-ups, policymakers and multinationals, bridging the gap between innovation and implementation in healthcare.

Currently, Hans is one of the driving forces behind FAQIR, a groundbreaking initiative aimed at empowering patients within a secure ecosystem of personal data vaults. Through this work, he helps hospitals, governments and other stakeholders leverage health data in an innovative, ethical and secure way, with the ultimate goal of delivering better care for everyone.